Philip Bonomi to Biomarkers
This is a "connection" page, showing publications Philip Bonomi has written about Biomarkers.
Connection Strength
0.221
-
The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310.
Score: 0.125
-
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials. J Thorac Oncol. 2009 Jul; 4(7):869-74.
Score: 0.068
-
Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Ann Thorac Surg. 2011 Nov; 92(5):1805-11; discussion 1811.
Score: 0.020
-
Does an inability to eradicate normal stem cells preclude the cure of some cancers? Med Hypotheses. 1996 Jul; 47(1):31-4.
Score: 0.007